2019 proved to be a pivotal year for the skin microbiome, as personal care giants Unilever launched their Dove range of ‘microbiome-friendly’ skincare products. Clearly, the biggest players in beauty and personal care have recognised the potential commercial value of skin microbiome-based consumer product claims and formulations.

Moving forward into 2021, the market will continue to see more and more products launched with microbiome claims backed through next-generation sequencing techniques. Including ingestible beauty products that influence the gut-skin axis, to truly personalised skincare solutions and mass market formulations – there’s a huge commercial opportunity to commercialise skin microbiome research into consumer care products.

So, what’s different at Microbiome Connect: Skin EU Virtual?

Six new topics to explore:

• The skin-gut axis and the development of ingestible beauty products.
• Personalisation of skin-microbiome products and formulation considerations.
• Defining skin-microbiome industry terminology and developing scientifically backed claims that resonate with consumers.
• Next generation sequencing techniques and their application in claims development.
• New data demonstrating the role of the microbiome in common skin conditions including acne, eczema and dandruff.
• The vaginal and oral microbiomes and the mass market product development opportunities to treat gingivitis/periodontitis and sexually transmitted infections.

All tickets to tune into this event are 2FOR1 – simply quote this when booking online!